— Corporate governance — Executive Committee

Executive Committee

The Board of Directors delegates executive management powers to the CEO. The CEO delegates the appropriate powers to the members of the Executive Committee. The Organizational Regulations of the Board of Directors govern, among other things, the transfer of responsibilities from the Board of Directors to the CEO. The regulations can be viewed on medmix.swiss/en/Investors/Governance (under Downloads). There are no management contracts with third-parties. None of the Executive Committee members has a contract with a notice period exceeding 12 months. As of December 31, 2021, the Executive Committee consisted of three members.

Girts Cimermans, Chief Executive Officer and member of the Executive Committee, is a Latvian citizen born in 1969.

Binding interests: Member of the Board of Directors of Alpcot Ltd.
Before the incorporation and separate listing of medmix Ltd, Girts Cimermans was, since 2019, Division President of Sulzer Ltd’s Applicator Systems division and member of the Sulzer Executive Committee. Starting in 2014, Girts Cimermans served as CEO of Hoya Vision Care in Bangkok and Amsterdam. From 2011 to 2013, he was President Europe Middle East & Africa of Pentax Medical in Germany and from 2009 to 2011 Director Eastern Europe of Danaher Group’s Kavo Dental GmbH. Prior to this, Girts held several positions at GE Healthcare in Germany, including President Northeastern Europe. He holds a Master’s Degree from the Stockholm School of Economics, Stockholm, Sweden.

Jennifer Dean, Chief Financial Officer and member of the Executive Committee, is an Australian citizen born in 1968.

Before the incorporation and separate listing of medmix Ltd, Jennifer Dean acted as the Chief Financial Officer for the Applicator Systems division of Sulzer Ltd (since 2017). From 2015 to 2017, she was CFO for Product Lines at GE Power Services. Prior to this, she held a number of positions at Alstom, including Vice President Finance for the Thermal Services division (2013 to 2015), Finance Director for Gas Turbine Product Line (2010 to 2013), and Finance Director for Environmental Control Systems & Carbon Capture Systems (2006 to 2010). Jennifer Dean holds a Bachelor's Degree in Economics from Macquarie University, Sydney, Australia and is a chartered accountant (Chartered Accountants Australia & New Zealand) and associate member of the Governance Institute of Australia.

Itee Satpathy, Chief Human Resources Officer and member of the Executive Committee, is a Swiss citizen born in 1978.¹⁾

Before joining medmix Ltd, Itee Satpathy was appointed Global Head of People Development and Internal Communications at Sulzer in 2018. Prior to joining Sulzer, she led Talent Development and Diversity at Syngenta (2013 to 2017). Previously, she held various roles of increasing responsibility at Novartis across the Human Resources function, including leadership and organization development, talent management and diversity and inclusion (2003 to 2012). Itee started her career in India with ICICI Bank before moving to Switzerland in 2003. Itee Satpathy holds a Master’s Degree (Diploma) in Human Resources Management from XLRI School of Management, Jamshedpur, India.

1) Itee Satpathy took over the position of Chief Human Resources Officer from Friedrich von Gadow effective as of December 1, 2021.

Additional mandates of members of the Executive Committee outside the medmix group

No member of the Executive Committee may hold more than five mandates, of which no more than one may be in listed companies (see art. 33 of the Articles of Association on medmix.swiss/en/Investors/Governance; under Downloads). Exceptions (e.g. for mandates held at the request of medmix or mandates in charity organizations) are also defined in art. 33 of the Articles of Association. All members of the Executive Committee comply with these requirements and no exceptions were granted in the reporting period.